Trump picks fight with drugmakers with last-minute drug pricing rules

Published



The Trump administration issued two final rules Friday aimed at lowering prescription drug costs, seeking to advance President Trump’s “America First Healthcare Plan” and picking a fight with drugmakers two months before the end of his term.

The regulatory effort is notable in that it brings the Republican Party into open conflict with the pharmaceutical industry and is one of the few Trump initiatives that could be solidified under President-election Joe Biden.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.